Skip to content
CancerIndex

Publication

Chapuy et al. Nat Med 2018

Authors not recorded

2018PMID 29713087stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CBIOPORTAL-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 1

Curated evidence

Evidence citing this paper (17)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
29713087
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–17 of 17 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
BCL11A Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11935

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
H1-3 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11946

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
H1-5 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11945

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
H2AC17 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11948

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
H2AC6 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11947

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
H2BC12 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11950

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
HLA-A Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11951

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
HLA-B Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11952

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
HLA-C Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11953

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
HVCN1 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11954

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
LTB Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11961

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
LYN Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity2submitted
EID11962

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations. The rate of mut… (full text at CIViC)

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
MEF2C Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11963

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
POU2F2 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity3submitted
EID11977

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
PRKCB Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity3submitted
EID11978

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
SIN3A mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11984

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic
ZFP36L1 Mutation1
(oncogenic)Diffuse Large B-Cell LymphomaCURATED_BROADEROncogenicESupports Oncogenicity4submitted
EID11997

The authors analyzed 304 primary DLBCLs using whole exome sequencing and targeted sequencing. This one one of the genes they identified as significantly enriched for somatic mutations.

PMID 29713087 · Chapuy et al., 2018 · Open in CIViC

civic